Common use of Collaborative Development of Products Clause in Contracts

Collaborative Development of Products. The Parties will each diligently collaborate in the Pre-Clinical Development and Development and use commercially reasonable efforts to develop and bring Products to the market as soon as reasonably practicable. The role of each Party in the Development process will be determined by the JDC, with the Parties intending that each Party will provide advisory and supporting services with respect to each phase of the process in which such Party is not actively or primarily involved. [ * ] shall supply [ * ] for each Product to be promoted or co-promoted by the Parties in the Territory in the aggregate, as determined by the JDC. A Party's required Development effort is hereinafter referred to as its ("Required Development Effort"). The JDC will determine appropriate written standards for measuring Required Development Efforts and accounting procedures to confirm and document each Party's performance of its Required Development Effort for any Product before the Parties commence Development thereof. No clinical trials involving any Product shall be commenced by or on behalf of either Party without the prior approval of the JDC. Nothing contained in this Section 3(d) shall be deemed to preclude either Party from terminating its participation in the collaborative Development, pursuant to Section 3(l), at such time. Any decision by a Party not to participate in development pursuant to Section 3(b) or to terminate participation in the collaborative Development pursuant to Section 3(l) shall not be deemed a breach of this Agreement.